Cancer Terminology Thursday / Jueves de Terminología del Cáncer
It’s Cancer Terminology Thursday! This week’s term is BRCA1. 📚🔬🧬🩺 Feliz Jueves de terminología del cáncer! El término de esta semana es BRCA1. 📚🔬🧬🩺 #CaRE2#CancerHealthEquity#CancerResearch#InvestigacíonSobreelCáncer
Training Tuesday!
Congratulations to CaRE2 postbac, Johnny Velasquez, who is the recipient of the ABRCMS travel award and will be presenting his poster presentation on “Downregulation of plasma-derived miR-17-5p in low risk prostate cancer patients following proton therapy.” 👏 #CaRE2HEC #ABRCMS #CancerResearch #TrainingTuesday
CaRE2 at the “Tú Ventanilla de Salud”event hosted by the Mexican Consulate
On Saturday October 7th, 2023 our COC team partnered with the UF CTSI Mobile Health Clinic, UF Healthstreet and UF/IFAS to provide individuals at the Mexican Consulate of Orlando, FL FREE health education and medical services. The team administered 17 flu vaccines, and 13 health screenings. We also added 5 individuals to our contact registry […]
#FeatureFriday – Community Outreach Core
On this #FeatureFriday, we spotlight our Community Outreach Core, who continues to disseminate their work into the community. Our team has recently published 2 manuscripts and presented 3 posters at the AACR Cancer Health Disparities Conference in Orlando, FL👏 Find their manuscripts here: https://pubmed.ncbi.nlm.nih.gov/37452225/ https://pubmed.ncbi.nlm.nih.gov/37642919/
CaRE2 Center Publication
Congratulations to our CaRE2 center for publishing a piece on our center’s structure, innovation, and initial outcomes. Read more here: https://ow.ly/QKVT50PVff2
Pink October – Breast Cancer Awareness Month
October is #BreastCancerAwarenessMonth! Learn about different risk factors and breast cancer screening guidelines. Consult your primary care physician and ask when the time is right to get screened. 🧬🔬🩻👨⚕️👩⚕️💗
Training Tuesday!
Congratulations to CaRE2 postbac, Steven Ewell, who is the recipient of the ABRCMS travel award and will be presenting his poster presentation on “In-Silico Identification of Oxa/thiazole Carboxamides as Potential Breast Cancer Therapeutic Agents with Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitory Effect.” 👏 #CaRE2HEC #ABRCMS #CancerResearch #TrainingTuesday
John D. Carpten, PhD, inducted into the 2023 National Academy of Medicine
John D. Carpten, Ph.D., one of the founding MPIs for CaRE2, is a 2023 inductee into the National Academy of Medicine. We are so proud of Dr. Carpten!!🎉👏🥼 Read more here: https://ow.ly/6nh450PUK57.
Indigenous People’s Day
CaRE2 celebrates Indigenous People’s Day! We recognize our CaRE2 members and their strides in research for Indigenous People. They have published 30+ research papers; a few can be found here. Great work!! We recognize: Drs. Scarton, Soto, Begay, Marconett, Webb, and Mason #IndigenousPeoplesDay #IndigenousPeoplesResearch #CaRE2HEC
National Liver Cancer Awareness Month
October is National Liver Cancer Awareness Month. Latinos suffer two times higher rates of liver cancer than their white peers (American Cancer Society). Join us in making a difference in cancer health disparities! 🎗 Octubre es el Mes Nacional de Concienciación sobre el Cáncer de Hígado. Los latinos padecen dos veces más de cáncer de […]
